- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2014
- Public Summary Document (PSD) July 2014 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2014 PBAC Meeting - Word
Ruxolitinib – July 2014
Ruxolitinib, 5mg, 15mg, 20mg tablets, Jakavi®, Novartis Pharmaceuticals Australia Pty Ltd
Last updated
8 November 2023